PEAK6
IDYA icon

PEAK6’s IDEAYA Biosciences IDYA Stock Holding History

PEAK6’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.2K Buy
+2,017
New +$61.7K ﹤0.01% 2442

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PEAK6's IDYA Position: Q2 2026 in Review

PEAK6 opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 2,017 shares worth $75.2K. The stake represents ﹤0.01% of the portfolio and ranks #2442 among its holdings.

285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • PEAK6 held 2,017 shares of IDEAYA Biosciences worth $75.2K as of Q2 2026.
  • IDEAYA Biosciences was a new PEAK6 position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2442 holding.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.